Adapthealth CorpAHCO
ASignal's systematic analysis rates AHCO as Bearish.
Reflects the latest available analysis · analyzed Aug 22, 2026
The case on AHCO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Revenue growth of 12.7% YoY indicates moderate top-line expansion
- Low price-to-sales ratio of 0.22x suggests potential undervaluation
- Price near Bollinger Lower Band (2.52) signals possible oversold reversal
- RSI at 12.96 indicates deeply oversold conditions, potentially bullish
- Negative free cash flow of $-80.69M raises sustainability concerns
- Negative return on equity (-15.22%) reflects poor capital efficiency
- High debt-to-equity ratio of 1.49x indicates elevated financial risk
- MACD below signal line with negative histogram suggests ongoing downtrend
- Low quick ratio of 0.64x signals potential liquidity pressure
See the full verdict on AHCO
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AHCO
Most investors never get a second opinion, let alone several. ASignal runs AHCO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.